HELP Reports $0 Revenue, $0 EPS, Phase 2 GAD Study Shows 10-Point HAM-A Improvement, 67% Responders, 39% Remission, 90-Minute Acute Effects, No Serious AEs
Cybin Inc. Common Stock · Now $4.69
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS